HIV-1 reverse transcriptase drug-resista
✍
Sherri T. Burda; Ragupathy Viswanath; Jiangqin Zhao; Thompson Kinge; Christopher
📂
Article
📅
2010
🏛
John Wiley and Sons
🌐
English
⚖ 118 KB
## Abstract The most common first‐line, highly active anti‐retroviral therapy (HAART) received by individuals infected with HIV‐1 in Cameroon is the combination therapy Triomune, comprised of two nucleoside reverse transcriptase inhibitors (NRTI) and one non‐NRTI (NNRTI). To examine the efficacy of